PavanBachireddyMD

Hematologic Oncology

Clinical Fellow in Medicine, Brigham and Women's Hospital

Dr. Bachireddy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016
Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2012
Stanford University School of MedicineClass of 2009

PubMed

1 citations
GPR56 in GVL: marker or mechanism?
Audra N Iness, Pavan Bachireddy
Blood. 2024-03-28
8 citations
ZNF683 marks a CD8T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.
Erin M Parry, Camilla K Lemvigh, Stephanie Deng, Nathan Dangle, Neil Ruthen
Cancer Cell. 2023-10-09
27 citations
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.
Livius Penter, Yang Liu, Jacquelyn O Wolff, Lin Yang, Len Taing
Blood. 2023-04-13

Abstracts/Posters

Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
Pavan Bachireddy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
T Cell Determinants of Response and Resistance to PD-1 Blockade in RichterÍs Transformation
Pavan Bachireddy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Damon Runyon Cancer Research Foundation Awards $3.6 Million to Top Clinical InvestigatorsJuly 21st, 2023